Anti-Human APP Recombinant Antibody(Donanemab)

Product Information

Catalog Number	YR1541
Product Name	Anti-Human APP Recombinant Antibody(Donanemab)
Molecular Name	Donanemab
Alias	Anti-APP Recombinant Antibody, Research Grade Donanemab
CAS Number	1931944-80-7
Target	APP[Homo sapiens]
Isotype	IgG1 Kappa
Clonity	Monoclonal
Source	CHO Cells
Size	1mg, 5mg
Concentration	1mg/ml
Purity	>95% as determined by SDS-PAGE
Buffer	PBS, pH7.5
Background	Donanemab (USAN, development code LY3002813) is a biological drug in trial to treat early symptoms of Alzheimer's disease. There is no cure or treatment for Alzheimer’s disease. Donanemab has shown positive results in Eli Lilly and Co.’s first two trials.
Storage	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Note	This product is for research use only.

Cat#	Product Name	Species	Host	Applications	Size	Price